Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 06:11 am Purchase | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,075,000 7.89% | 100,200 (+1.68%) | View |
| 2023-02-09 11:27 am Sale | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 3,976,853 5.16% | -102,170 (-2.50%) | View |
| 2023-01-31 5:52 pm Sale | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 4,952,737 6.4% | -170,098 (-3.32%) | View |
| 2022-02-10 08:28 am Purchase | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 4,079,023 5.32% | 4,079,023 (New Position) | View |
| 2022-02-02 7:11 pm Sale | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 5,122,835 6.7% | -389,429 (-7.06%) | View |
| 2022-01-31 8:38 pm Sale | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 5,974,800 7.8% | -535,200 (-8.22%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,510,000 8.65% | 1,384,000 (+27.00%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 5,512,264 7.3% | 2,506,097 (+83.37%) | View |
| 2020-06-09 4:32 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 3,006,167 4.8% | 176,523 (+6.24%) | View |
| 2020-05-21 4:15 pm Purchase | 13D | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 11,387,656 17% | 363,636 (+3.30%) | View |
| 2020-03-25 5:11 pm Purchase | 13D | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 11,024,020 18.9% | 1,450,000 (+15.15%) | View |
| 2020-02-14 11:19 am Sale | 13G | Ocular Therapeutix, Inc. OCUL | Versant Side Fund III L.P. | 2,215,384 4.6% | -6,944 (-0.31%) | View |
| 2020-02-10 4:07 pm Sale | 13G | Ocular Therapeutix, Inc. OCUL | Man Group plc | 760,490 1.58% | -1,697,297 (-69.06%) | View |
| 2020-02-05 12:16 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 2,829,644 5.9% | 36,892 (+1.32%) | View |
| 2020-01-10 4:30 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 5,126,000 10.66% | 2,926,000 (+133.00%) | View |
| 2019-05-31 4:40 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | Man Group plc | 2,457,787 5.74% | 2,457,787 (New Position) | View |
| 2019-05-03 5:15 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 2,200,000 5.14% | 2,200,000 (New Position) | View |
| 2019-04-01 4:30 pm Unchanged | 13D | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 9,574,020 19.7% | 0 (Unchanged) | View |
| 2019-03-04 5:28 pm Purchase | 13D | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 9,574,020 17.8% | 5,769,232 (+151.63%) | View |
| 2019-02-14 4:37 pm Purchase | 13G | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 3,804,788 9.3% | 777,300 (+25.67%) | View |